Global Patient Blood Management Market is valued at approximately USD 12.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.3% over the forecast period 2022-2029. Patient Blood Management is a multidisciplinary approach to caring for patients who might need a blood transfusion. The Patient Blood Management market is expanding because of factors such as rising incidence of trauma and accidents that causes blood loss and Increasing in the prevalence of blood cancer.
According to the Statista, the number of road-traffic related injuries in the United States has decreased by roughly 17 percent between 2019 and 2020, whereas fatalities increased by almost 8 percent. Between 2010 and 2020, road traffic injuries in the United States grew by nearly 34,000 incidents to some 2.28 million road traffic related injuries in 2020. Over the same period, fatalities also increased by about 5,800. Another important component driving space is Increasing in the prevalence of blood cancer. As per Statista, in 2020, nearly 10 million deaths were caused by cancer worldwide- a number which is expected to reach over 16 million by 2040. In addition, in 2021, global oncology spending totaled 187 billion U.S. dollars. In comparison, costs stood at 86 billion dollars six years earlier. However, lack of awareness regarding blood donation stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Patient Blood Management Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the space in terms of revenue, owing to the rise in the number of hospitals and growing elderly population that is vulnerable to blood diseases. Moreover, North America is expected to grow significantly during the forecast period, owing to factors such as Increasing Government initiatives and nonprofit organizations in the market space.
Major market players included in this report are:
- Grifols, S.A.
- B. Braun SE
- Immucor, Inc
- Haemonetics Corporation
- LivaNova PLC
- Biomerieux SA
- Haier Biomedical
- Macopharma
- Terumo Corporation
- Asahi Kasei Corporation
Recent Developments in the Market:
- In February 2022, Biocon announced the acquisition of Viatris' biosimilar portfolio for USD 3.335 billion. This acquisition strengthened Biocon's biosimilar product portfolio and improved its revenue generation.
Global Patient Blood Management Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Component, End User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Instruments
- Accessories
- Reagents and Kits
- Software
By Component:
- Whole Blood and Red Blood Cells
- Plasma
By End User:
- Blood Banks
- Hospitals
- Diagnostic Clinics and Pathology Labs
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Patient Blood Management Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Patient Blood Management Market, by Product, 2019-2029 (USD Billion)
- 1.2.3. Patient Blood Management Market, by Component, 2019-2029 (USD Billion)
- 1.2.4. Patient Blood Management Market, by End User, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Patient Blood Management Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Patient Blood Management Market Dynamics
- 3.1. Patient Blood Management Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising incidence of trauma and accidents that causes blood loss
- 3.1.1.2. Increasing in the prevalence of blood cancer
- 3.1.2. Market Challenges
- 3.1.2.1. Lack of awareness regarding blood donation
- 3.1.3. Market Opportunities
- 3.1.3.1. Increase in government healthcare expenditure
Chapter 4. Global Patient Blood Management Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Investment Adoption Model
- 4.5. Analyst Recommendation & Conclusion
- 4.6. Top investment opportunity
- 4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Patient Blood Management Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Patient Blood Management Market by Product, Performance - Potential Analysis
- 6.3. Global Patient Blood Management Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
- 6.4. Patient Blood Management Market, Sub Segment Analysis
- 6.4.1. Instruments
- 6.4.2. Accessories
- 6.4.3. Reagents and Kits
- 6.4.4. Software
Chapter 7. Global Patient Blood Management Market, by Component
- 7.1. Market Snapshot
- 7.2. Global Patient Blood Management Market by Component, Performance - Potential Analysis
- 7.3. Global Patient Blood Management Market Estimates & Forecasts by Component 2019-2029 (USD Billion)
- 7.4. Patient Blood Management Market, Sub Segment Analysis
- 7.4.1. Whole Blood and Red Blood Cells
- 7.4.2. Plasma
Chapter 8. Global Patient Blood Management Market, by End User
- 8.1. Market Snapshot
- 8.2. Global Patient Blood Management Market by End User, Performance - Potential Analysis
- 8.3. Global Patient Blood Management Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
- 8.4. Patient Blood Management Market, Sub Segment Analysis
- 8.4.1. Blood Banks
- 8.4.2. Hospitals
- 8.4.3. Diagnostic Clinics and Pathology Labs
Chapter 9. Global Patient Blood Management Market, Regional Analysis
- 9.1. Patient Blood Management Market, Regional Market Snapshot
- 9.2. North America Patient Blood Management Market
- 9.2.1. U.S. Patient Blood Management Market
- 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
- 9.2.1.2. Component breakdown estimates & forecasts, 2019-2029
- 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Patient Blood Management Market
- 9.3. Europe Patient Blood Management Market Snapshot
- 9.3.1. U.K. Patient Blood Management Market
- 9.3.2. Germany Patient Blood Management Market
- 9.3.3. France Patient Blood Management Market
- 9.3.4. Spain Patient Blood Management Market
- 9.3.5. Italy Patient Blood Management Market
- 9.3.6. Rest of Europe Patient Blood Management Market
- 9.4. Asia-Pacific Patient Blood Management Market Snapshot
- 9.4.1. China Patient Blood Management Market
- 9.4.2. India Patient Blood Management Market
- 9.4.3. Japan Patient Blood Management Market
- 9.4.4. Australia Patient Blood Management Market
- 9.4.5. South Korea Patient Blood Management Market
- 9.4.6. Rest of Asia Pacific Patient Blood Management Market
- 9.5. Latin America Patient Blood Management Market Snapshot
- 9.5.1. Brazil Patient Blood Management Market
- 9.5.2. Mexico Patient Blood Management Market
- 9.6. Rest of The World Patient Blood Management Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Grifols, S.A.
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. B. Braun SE
- 10.2.3. Immucor, Inc
- 10.2.4. Haemonetics Corporation
- 10.2.5. LivaNova PLC
- 10.2.6. Biomerieux SA
- 10.2.7. Haier Biomedical
- 10.2.8. Macopharma
- 10.2.9. Terumo Corporation
- 10.2.10. Asahi Kasei Corporation
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption